Synopsis
Synopsis
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cysteine
2. Cysteine Hydrochloride
3. Half Cystine
4. Half-cystine
5. L Cysteine
6. L-cysteine
7. Zinc Cysteinate
1. 52-89-1
2. L-cysteine.hcl
3. L-cysteine Hydrochloride Anhydrous
4. L-cysteine, Hydrochloride
5. L-cysteine Hcl Anhydrous
6. (r)-cysteine Hydrochloride
7. (r)-2-amino-3-mercaptopropanoic Acid Hydrochloride
8. L-cysteine Hcl
9. L-(+)-cysteine Hydrochloride
10. Cysteine Hydrochloride
11. Cysteine Monohydrochloride
12. L-cysteine, Hcl
13. L-cysteine Monohydrochloride
14. Cysteine Hcl
15. Cystein Chloride
16. Cysteine Hcl (anhydrous)
17. Cysteine Hydrochloride (anhydrous)
18. Cysteine, L-, Hydrochloride
19. Cysteine Hydrochloride Anhydrous
20. L-cysteine, Hydrochloride (1:1)
21. Cysteine Chlorhydrate
22. L-cysteine (hydrochloride)
23. H-cys-oh.hcl
24. Nsc 8746
25. A9u1687s1s
26. 3-mercaptoalanine Hydrochloride
27. Ek 2367
28. Cysteine (as Hydrochloride)
29. Ccris 3613
30. Cysteine, L-, Monohydrochloride
31. Nsc-755898
32. Einecs 200-157-7
33. Wr 348
34. Cysteine-hcl
35. Unii-a9u1687s1s
36. Ai3-18781
37. L-cysteine Hydrochloride, Anhydrous
38. Mfcd00064553
39. Cysteine-hydrochloride
40. L-cysteinium Chloride
41. H-cys-oh?cl
42. L-cysteine Chlorhydrate
43. Dsstox_cid_367
44. L-cysteine Hydro-chloride
45. L-cysteine Hydrochloride;
46. Ec 200-157-7
47. Dsstox_rid_75543
48. Dsstox_gsid_20367
49. Schembl18161
50. L-cysteinemethyl Hydrochloride
51. L-2-amino-3-mercaptopropanoic Acid Monohydrochloride
52. Chembl1200630
53. Dtxsid0020367
54. Chebi:91247
55. Hy-y0337a
56. Tox21_200699
57. S4815
58. Akos015849225
59. Ccg-266272
60. Cs-w018517
61. Cysteine Hydrochloride [who-dd]
62. Cas-52-89-1
63. Cysteine Hydrochloride, Anhydrous
64. (r)-(+)-cysteine Hydrochloride Hydrate
65. Ncgc00258253-01
66. (2r)-2-amino-3-mercapto-propionic Acid
67. Ac-12796
68. As-11682
69. L-cysteine Hydrochloride [usp-rs]
70. L-cysteine Hydrochloride, 98.0-102.0%
71. Cysteine Hydrochloride Anhydrous [ii]
72. Cysteine Hydrochloride Anhydrous [mi]
73. (r)2-amino-3-thiopropanoic Acid Hydrochloride
74. E72644
75. (r)-2-amino-3-mercaptopropanoicacidhydrochloride
76. 064c553
77. A829298
78. (1r)-1-carboxy-2-sulfanylethan-1-aminium Chloride
79. (2r)-2-amino-3-sulfanylpropanoic Acid;hydrochloride
80. J-019666
81. L-cysteine Hydrochloride, Anhydrous, >=98% (tlc)
82. W-105789
83. L-cysteine Hydrochloride, Anhydrous, >=99.0% (rt)
84. Q27163158
85. L-cysteine Hydrochloride, Fg, Product Of Wacker Chemie Ag
86. L-cysteine Hydrochloride, Vetec(tm) Reagent Grade, >=98%
87. (2r)-2-amino-3-sulfanyl-propanoic Acid Hydrochloride;h-cys-oh.hcl
88. L-cysteine Hydrochloride, Anhydrous, From Non-animal Source, Bioreagent, Suitable For Cell Culture, >=98.0%
| Molecular Weight | 157.62 g/mol |
|---|---|
| Molecular Formula | C3H8ClNO2S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 156.9964274 g/mol |
| Monoisotopic Mass | 156.9964274 g/mol |
| Topological Polar Surface Area | 64.3 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 75.3 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
Axplora- The partner of choice for complex APIs.
Certificate Number : R1-CEP 1997-014 - Rev 03
Issue Date : 2014-04-24
Type : Chemical
Substance Number : 895
Status : Valid
Date of Issue : 2022-06-24
Valid Till : 2025-07-02
Written Confirmation Number : WC-0102
Address of the Firm :
| Available Reg Filing : EU |
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-08-14
Pay. Date : 2018-07-02
DMF Number : 21364
Submission : 2008-02-26
Status : Active
Type : II
Registration Number : 220MF10016
Registrant's Address : 575 Shimada-cho, Ashikaga City, Tochigi Prefecture
Initial Date of Registration : 2008-01-09
Latest Date of Registration : --
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-10-27
Pay. Date : 2017-03-14
DMF Number : 8866
Submission : 1990-11-30
Status : Active
Type : II
Registration Number : 220MF10229
Registrant's Address : 452 Oshiba, Mobara City, Chiba Prefecture
Initial Date of Registration : 2008-11-17
Latest Date of Registration : --
NDC Package Code : 53884-1013
Start Marketing Date : 2023-01-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10741
Submission : 1994-02-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1930
Submission : 1972-05-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2753
Submission : 1976-10-15
Status : Inactive
Type : II
NDC Package Code : 12497-1013
Start Marketing Date : 1978-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Registration Number : 217MF10553
Registrant's Address : 575 Shimada-cho, Ashikaga City, Tochigi Prefecture
Initial Date of Registration : 2005-09-09
Latest Date of Registration : --
NDC Package Code : 17333-909
Start Marketing Date : 2008-06-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2753
Submission : 1976-10-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1930
Submission : 1972-05-09
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-08-14
Pay. Date : 2018-07-02
DMF Number : 21364
Submission : 2008-02-26
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10741
Submission : 1994-02-28
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-10-27
Pay. Date : 2017-03-14
DMF Number : 8866
Submission : 1990-11-30
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Axplora- The partner of choice for complex APIs.
Axplora- The partner of choice for complex APIs.
Cysteine Hydrochloride Monohydrate
Certificate Number : R1-CEP 1997-014 - Rev 03
Status : Valid
Issue Date : 2014-04-24
Type : Chemical
Substance Number : 895
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
Japanese Pharmacopoeia L-Ethylcysteine Hydrochloride
Registration Number : 219MF10005
Registrant's Address : 4-2-2 Nihonbashi Honcho, Chuo Ward, Tokyo
Initial Date of Registration : 2007-01-18
Latest Date of Registration : 2007-01-18
L-Cysteine hydrochloride (monohydrate) (Nippon Pro)
Registration Number : 217MF10553
Registrant's Address : 575 Shimada-cho, Ashikaga City, Tochigi Prefecture
Initial Date of Registration : 2005-09-09
Latest Date of Registration : 2007-08-07
Japanese Pharmacopoeia L-Cysteine Hydrochloride Hydrate "For manufacturing only"
Registration Number : 220MF10016
Registrant's Address : 575 Shimada-cho, Ashikaga City, Tochigi Prefecture
Initial Date of Registration : 2008-01-09
Latest Date of Registration : 2008-01-09
Japanese Pharmacopoeia L-Cysteine Hydrochloride Hydrate (for manufacturing only)
Registration Number : 220MF10229
Registrant's Address : 452 Oshiba, Mobara City, Chiba Prefecture
Initial Date of Registration : 2008-11-17
Latest Date of Registration : 2008-11-17
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Axplora- The partner of choice for complex APIs.
L-Cysteine HCl Monohydrate Ph. Eur
Date of Issue : 2022-06-24
Valid Till : 2025-07-02
Written Confirmation Number : WC-0102
Address of the Firm : Plot No.B5 & B6, A1&A2, MEPZ- Tambaram, Chennai-600045
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
NDC Package Code : 17333-909
Start Marketing Date : 2008-06-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12497-1013
Start Marketing Date : 1978-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 53884-1013
Start Marketing Date : 2023-01-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 10695-128
Start Marketing Date : 2024-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Axplora- The partner of choice for complex APIs.
About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
About the Company : The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practic...
L-Cysteine Hydrochloride Monohydrate
About the Company : Apotex Pharmachem is a global fully integrated API R&D and manufacturing organization with its headquarters located in Brantford, Ontario, Canada and is a member of the Apotex grou...
L-Cysteine Hydrochloride Monohydrate
About the Company : We specialize in the supply of API and API related intermediates and services. A significant part of our business comes from the process/production development tailored to our cust...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - 2500MG/50ML (...DOSAGE - SOLUTION;INTRAVENOUS - 2500MG/50ML (50MG/ML)
USFDA APPLICATION NUMBER - 210660
DOSAGE - SOLUTION;INTRAVENOUS - 500MG/10ML (5...DOSAGE - SOLUTION;INTRAVENOUS - 500MG/10ML (50MG/ML)
USFDA APPLICATION NUMBER - 210660
Digital Content
NEWS #PharmaBuzz
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
